PATENT CLAIM ANALYSIS

Application Number: 16130820
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "021800"]

Abstract:
New polypeptide agonists of AT2R are disclosed, as well as pharmaceutical compositions comprising the agonists, methods of their use in the treatment of diseases, conditions or disorders characterized by insufficient AT2R activity or excessive AT1R activity, and methods of their use as laboratory reagents for research purposes.

Claim (Index 5):
The method of  claim 1  wherein said AT2R agonist is administered to a mammal in need of treatment for an injury selected from the group consisting of spinal cord injury, traumatic brain injury, and brain lesions.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15595517', '15648184', '14773041', '13896937', '12046038']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7632292112586637
- 35 USC 102 Novelty (BERT): 0.5789740718140608
- Combined Prediction Score: 0.7448036973142035
- Mean Citation Score: 298.427244
- Max Citation Score: 609.76044
- Similarity Product: 339.32842460809

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test